Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RegenHeart: Umbilical Cord MSCs in Non-ischemic Dilated Cardiomyopathy
NCT04325594Phase 2Completed
- Sponsor
- Scientific-Clinical Center for Cardiac Surgery and Transplantology
- Start
- Mar 2020
- Primary completion
- Jan 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of umbilical cord-derived mesenchymal stromal cells in dilated cardiomyopathy (DCM) and chronic heart failure (CHF), sponsored by Scientific-Clinical Center for Cardiac Surgery and Transplantology. Primary endpoint: Incidence of ischemic and arrhythmic events, abnormal laboratory and ECG findings at 5 days. Started Mar 2020; status: completed.
02
Drugs
umbilical cord-derived mesenchymal stromal cells
03
Conditions
dilated cardiomyopathy (DCM)chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT04325594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04325594.